The global tangential flow filtration market size is expected to reach USD 4.13 billion by 2030, registering to grow at a CAGR of 12.4% from 2025 to 2030 . The major factors contributing to the market growth are the advantages offered by tangential flow filtration (TFF) over normal flow filtration, the increasing demand for vaccines and therapeutics derived from bioprocessing operations, and the rising investments for exhaustive R&D activities to develop new technologies in TFF.
The use of TFF technology increased during the COVID-19 pandemic as the separation process was widely employed during the vaccine manufacturing process. TFF products observed an increased adoption during COVID-19 research for the development and manufacturing of vaccines as treatment plans. The pandemic also witnessed an increase in the usage of single-use bioprocessing systems, which further fueled the market expansion. In addition, several initiatives by the governments and key manufacturers were introduced to boost the vaccine development for curbing the spread of SARS-CoV-2 infection. For instance, in April 2021, Meissner Filtration Products, Inc. announced that it has secured a contract of USD 13.4 million from the U.S. government, BARDA (Biomedical Advanced Research and Development Authority) to expand its capacity and produce single-use systems to support the manufacturing of vaccines for COVID-19. Thereby, the increased production of vaccines has positively impacted the TFF product demand and fueled its growth.
TFF or sometimes referred to as cross-flow filtration is a technique used for the separation and purification of molecules, wherein the feed solution flows in a parallel direction to the membrane filter. During this process, some of the flow streams pass through the filter while the rest is concentrated by recirculation in the system. The TFF technology is utilized across both upstream and downstream processes due to its numerous advantages such as low running costs, enhanced control and efficiency, reduced cross-contamination, easy scale-up or down, and increased shelf life. These advantages have allowed TFF application in a range of fields such as biochemistry, molecular biology, and immunology. Additionally, the increasing demand for biopharmaceuticals due to lesser side effects, personalized treatments, and novel therapies has resulted in the expansion of manufacturing capabilities. CMOs and CROs also witnessed a rise in the manufacturing of vaccines and therapeutics due to the upswing in the demand for commercial biopharmaceuticals. For instance, in June 2022, Merck KGaA announced expanding its existing CDMO facility in Wisconsin, USA. This new expansion project of USD 58 million (EUR 59 million) is targeted to increase the production of highly potent active pharmaceutical ingredients for meeting the growing demand for therapies for critical cancer. The rise in the manufacturing of and demand for biopharmaceuticals attributes to the adoption of TFF products across harvesting, separation, and purification processes, therefore propelling the growth of the marketplace.
This product will be delivered within 1-3 business days.
The use of TFF technology increased during the COVID-19 pandemic as the separation process was widely employed during the vaccine manufacturing process. TFF products observed an increased adoption during COVID-19 research for the development and manufacturing of vaccines as treatment plans. The pandemic also witnessed an increase in the usage of single-use bioprocessing systems, which further fueled the market expansion. In addition, several initiatives by the governments and key manufacturers were introduced to boost the vaccine development for curbing the spread of SARS-CoV-2 infection. For instance, in April 2021, Meissner Filtration Products, Inc. announced that it has secured a contract of USD 13.4 million from the U.S. government, BARDA (Biomedical Advanced Research and Development Authority) to expand its capacity and produce single-use systems to support the manufacturing of vaccines for COVID-19. Thereby, the increased production of vaccines has positively impacted the TFF product demand and fueled its growth.
TFF or sometimes referred to as cross-flow filtration is a technique used for the separation and purification of molecules, wherein the feed solution flows in a parallel direction to the membrane filter. During this process, some of the flow streams pass through the filter while the rest is concentrated by recirculation in the system. The TFF technology is utilized across both upstream and downstream processes due to its numerous advantages such as low running costs, enhanced control and efficiency, reduced cross-contamination, easy scale-up or down, and increased shelf life. These advantages have allowed TFF application in a range of fields such as biochemistry, molecular biology, and immunology. Additionally, the increasing demand for biopharmaceuticals due to lesser side effects, personalized treatments, and novel therapies has resulted in the expansion of manufacturing capabilities. CMOs and CROs also witnessed a rise in the manufacturing of vaccines and therapeutics due to the upswing in the demand for commercial biopharmaceuticals. For instance, in June 2022, Merck KGaA announced expanding its existing CDMO facility in Wisconsin, USA. This new expansion project of USD 58 million (EUR 59 million) is targeted to increase the production of highly potent active pharmaceutical ingredients for meeting the growing demand for therapies for critical cancer. The rise in the manufacturing of and demand for biopharmaceuticals attributes to the adoption of TFF products across harvesting, separation, and purification processes, therefore propelling the growth of the marketplace.
Tangential Flow Filtration Market Report Highlights
- Single-use tangential flow filtration (TFF) systems led the market and accounted for the largest revenue share of 42.0% in 2024 attributed to the increasing adoption of single-use technologies across pharmaceutical companies, contract organizations, and research institutions.
- Ultrafiltration technology dominated the market and accounted for the largest revenue share, 55.8%, in 2024, owing to the rising demand for ultrapure water in the food and beverage, pharmaceuticals, and wastewater treatment sectors. In addition, stringent regulatory requirements regarding water quality and environmental sustainability compel industries to implement advanced filtration technologies.
- Raw material filtration led the market and accounted for the largest revenue share in 2024, owing to the increasing demand for high-quality raw materials across various industries, particularly in pharmaceuticals and food and beverage.
- Pharmaceutical and biotechnology companies dominated the market and accounted for the largest revenue share of 44.0% in 2024 attributed primarily to the increasing demand for biopharmaceuticals.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments
- Competitive Landscape: Explore the market presence of key players worldwide
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
The leading players in the Tangential Flow Filtration market include:
- Danaher Corporation
- Sartorius AG
- Parker-Hannifin Corporation
- Alfa Laval AG
- Merck KGaA
- Repligen Corporation
- FUJIFILM Wako Pure Chemical Corporation
- ABEC, Inc.
- Sterlitech Corporation
- Synder Filtration, Inc.
- Meissner Filtration Products, Inc.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Tangential Flow Filtration Market Variables, Trends, & Scope
Chapter 4. Tangential Flow Filtration Market: Product Business Analysis
Chapter 5. Tangential Flow Filtration Market: Technology Business Analysis
Chapter 6. Tangential Flow Filtration Market: Application Business Analysis
Chapter 7. Tangential Flow Filtration Market: End use Business Analysis
Chapter 8. Tangential Flow Filtration Market: Regional Estimates & Trend Analysis
Chapter 9. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Danaher Corporation
- Sartorius AG
- Parker-Hannifin Corporation
- Alfa Laval AG
- Merck KGaA
- Repligen Corporation
- FUJIFILM Wako Pure Chemical Corporation
- ABEC, Inc.
- Sterlitech Corporation
- Synder Filtration, Inc.
- Meissner Filtration Products, Inc.
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 100 |
Published | October 2024 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 2.05 Billion |
Forecasted Market Value ( USD | $ 4.13 Billion |
Compound Annual Growth Rate | 12.4% |
Regions Covered | Global |
No. of Companies Mentioned | 11 |